Epidemiology & Modelling
 Research Group


We conduct research in the following areas: • pharmacoepidemiology using large electronic health record datasets and disease registers • identification and prevention of adverse drug events • adherence to medication and related to health outcome • disease epidemiology (breast cancer, cardiovascular disease) • population health and health services research • health behaviour change methods We work with healthcare professionals, regulatory authorities, decision makers, researchers and patient representatives to address research questions and evidence of most relevance at the population level. Our backgrounds are in pharmacy, statistics, psychology, epidemiology, health service research and translational medicine. Our research is currently funded by the Health Research Board, Research Leaders Award (RL-15-1579), KEDs award (KED-17-012) and an Applied Partnership Award (APA-2017-0015).

About EMeRGe and our Mission

EMeRGe is an epidemiology research group led by Prof Kathleen Bennett at RCSI, Dublin.

The main pillars of research within EMeRGe include: Safe and Quality Medicines Adherence Cancer epidemiology Other disease modelling Here at EMeRGe , our mission is:    To improve population health outcomes through research evidence and to translate the evidence into effective decision making for policy and practice. In particular, to: promote safe, quality and effective medicines management and model disease epidemiology in cancer and cardiovascular disease.   Click Here to Discover More About Emerge

Our Research

There are four main pillars of research within the EMeRGe  research group Click on the icons to find our more about our research areas.

Safe & Quality Medicines

Prescribing of medicines is the most common healthcare intervention. Our research provides data and evidence on population based estimates and risk prediction of adverse drug events (ADEs) in the primary and secondary care settings. It includes the ADAPT study which is a prospective study examining the prevalence of ADRs in hospital admissions following an adverse drug event. It also includes research using large epidemiological studies of high risk medicines and associated outcomes.

Adherence

Medication adherence is the process by which patients consume their medications as prescribed by healthcare providers consisting of three distinct, yet inter-related phases; initiation, implementation and discontinuation.

Cancer Epidemiology

Cancer Epidemiology is the study of the distribution and determinants of the likelihood of cancer development. The research group have a particular focus on determinants and interventions in breast cancer, but also colorectal disease.

Other Disease Modelling

Modelling the underlying disease process and associated outcomes can help inform policy and practice by providing evidence on the potential effectiveness of interventions, or projected long term trends for planning. Previous research in this area has been in coronary heart disease (CHD IMPACT model) and the impact of health policies on influencing health determinants.

Study Publications

PDF Download

Recent study publications will be displayed here.

For full publication list click  on the below link. Study Publications Full List

Medication Adherence

Walsh CA, Mucherino S, Orlando V et al. Mapping the use of Group-Based Trajectory Modelling in medication adherence research: A scoping review protocol [version 1; peer review: awaiting peer review]. HRB Open Res 2020, 3:25 (https://doi.org/10.12688/hrbopenres.13056.1)

Read More

Safe and Quality Medicines

Mac Avin M, Teeling M, Bennett K. (2020). Trends in attention-deficit and hyperactivity disorder (ADHD) medications among children and young adults in Ireland: a repeated cross-sectional study from 2005 to 2015. BMJ Open. 2020 April 22.10. e035716. 10.1136/bmjopen-2019-035716. DOI: 10.1136/bmjopen-2019-035716

Read More

Disease Modelling

Marasigan V, Perry I, Bennett K, Balanda K, Capewell S, O’ Flaherty M, Kabir Z. Explaining the fall in Coronary Heart Disease mortality in the Republic of Ireland between 2000 and 2015 – IMPACT modelling study. Int J Cardiol. 2020 Mar 31. doi: 10.1016/j.ijcard.2020.03.067. PubMed PMID: 32276770

Read More

Safe and Quality Medicines

Tecklenborg S, Byrne C, Cahir C, Brown L, Bennett K.  Interventions to Reduce Adverse Drug Event-Related Outcomes in Older Adults: A Systematic Review and Meta-analysis. Drugs Aging. 2020 Feb;37(2):91-98. doi: 10.1007/s40266-019-00738-w. Review. Erratum in: Drugs Aging. 2020 Jan 27;:. PubMed PMID: 31919801. Read More

Safe and Quality Medicines

Moriarty F, Bennett K, Kenny RA, Fahey T, Cahir C. Comparing Potentially Inappropriate Prescribing Tools and Their Association With Patient Outcomes. J Am Geriatr Soc. 2020 Mar;68(3):526-534. doi: 10.1111/jgs.16239. Epub 2019 Nov 1. PubMed PMID: 31675114.

Read More

Safe and Quality Medicines

Walsh CA, Cahir C, Tecklenborg S, Byrne C, Culbertson MA, Bennett KE. The association between medication non-adherence and adverse health outcomes in ageing populations: A systematic review and meta-analysis. Br J Clin Pharmacol.

2019 Nov;85(11):2464-2478. doi: 10.1111/bcp.14075. Epub 2019 Sep 6. Review. PubMed PMID: 31486099; PubMed Central PMCID: PMC6848955. Read More

Meet Our Team

Meet our Team, Collaborators,  Partners and Intenational Advsiory Committee.

Our PartnersOur CollaboratorsIntenational Advsiory Committee

Prof. Kathleen Bennett

Associate Professor in Pharmacoepidemiology

Read More

Dr Caitriona Cahir

Research Fellow

Read More

Ms Sinéad Hand

Digital Media Specialist

Read More

Prof. Anne Hickey

Head of the Division of Population Health Sciences (PHS)

Read More

Dr Maeve Mullooly

Research

Read More

Dr Bernadine O’Donovan

Postdoctoral researcher

John Hughes

Jessica O’Driscoll

Aileen Burke

General Public Information

Here you will find excellent eduactional material and resources related to Emerge Research 

Responsive Design

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 


 learn more

Responsive Design

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 


 learn more

Responsive Design

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 


 learn more

Media & Dissemination

Here you can enjoy our media projects, presentations and much more

Presentations

Discover Emerge presentations 

Latest News

Stay up to date with all the latest new from Emerge 

New publication!

Only 12 days from submission to publication! Mapping the use of Group-Based Trajectory Modelling in medication adherence research: A scoping review protocol Caroline A. Walsh et al., published by Health[…]

Read more
May 21, 2020 0

Caroline Walsh MPSI Research Brief

MEDICATION NON-ADHERENCE AND ADVERSE HEALTH OUTCOMES IN AGEING POPULATIONS: AN ISSUE WORTH TACKLING? https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.14075

Read more
September 23, 2019 0

Professor Rachel Elliott

Professor Rachel Elliott, Professor of Health Economics at University of Manchester giving a seminar on ‘Using health economics to optimise medicines-taking in people with chronic illness’ in the Division of[…]

Read more
September 23, 2019 0

‘Know Check Ask’ campaign – invitation to participate in research

‘Know Check Ask’ campaign – invitation to participate in research   The WHO has a Global Patient Safety Challenge ‘Medication without harm’ to reduce harm associated with medicines by 50%[…]

Read more
September 30, 2020 0

The International Journal of Cardiology

Explaining the fall in Coronary Heart Disease mortality in the Republic of Ireland between 2000 and 2015 – IMPACT modelling study. Read more – https://www.internationaljournalofcardiology.com/article/S0167-5273(19)34157-9/pdf

Read more
May 11, 2020 0